<unk>  is a Vasopressin antagonist that is FDA approved for the treatment of raising serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia..   Common adverse reactions include hypertension, orthostatic hypotension, peripheral edema, phlebitis, injection site reaction, hypokalemia, increased thirst, constipation, diarrhea, vomiting, headache, increased frequency of urination, polyuria, fever.
Conivaptan
Tolvaptan
Bumetanide 
Amiloride
Paricalcitol 
Mannitol
Mitobronitol
Sorbitol 